Hopefully will get some more mature survive data on the ovarian cancer trial. The mean survival was 19.9 months but overall survival--when it becomes available i.e. mature--will be interesting. The abstracts were submitted based on data well before 1-16... probably about November, so they may have some more mature os to report. It looks like there will be some sort of audio presentation from ASCO? for both abstracts.
News 
Market Data 
Discover 
